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Abstract Human protein phosphatase-2Cc~ (PP2Cc~) was puri- 
fied to homogeneity after expression in Escherichla co~. AMP 
inhibited the dephosphorylation of AMP-activated protein kinase 
(AMPK), but not phosphocasein, by PP2Ca. The concentration 
dependence and the effects of other nucleotides (ATP and formy- 
cin A-5'-monophosphate) suggest hat AMP acts by binding to 
the same site which causes direct ailosteric activation of AMPK. 
A similar, although less pronounced, effect was observed with 
another protein phosphatase (PP2Ac). We have now shown that 
AMPK activates the AMPK cascade by four mechanisms, which 
should make the system exquisitely sensitive to changes in AMP 
concentration. 
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1. Introduction 
AMP:ATP ratio rather than to AMP per se. Since 
the AMP: ATP ratio is a sensitive indicator of the energy status 
of the cell [1,10], the AMPK cascade can be regarded as a 
cellular 'fuel gauge'. 
The active, phosphorylated form of AMPK can be inac- 
tivated in cell-free assays by either protein phosphatase-2A 
(PP2A) or protein phosphatase-2C (PP2C), the latter enzyme 
accounting for the majority of the AMPK phosphatase in a rat 
liver extract [11]. Experiments in isolated rat hepatocytes also 
suggest hat an okadaic acid-insensitive protein phosphatase, 
such as PP2C (but not PP2A, which is potently inhibited by 
okadaic acid) is responsible for dephosphorylation of AMPK 
in intact cells [12]. 
In this paper we report that, in addition to the three effects 
of AMP on the AMPK cascade described above, the nucleotide 
has a fourth effect, i.e. inhibition of the inactivation of active, 
phosphorylated AMPK by PP2C and PP2A. To facilitate the 
studies with PP2C, the human ~ isoform was expressed in 
Escherichia coli. 
The AMP-activated protein kinase (AMPK) is the central 
component of a protein kinase cascade which is activated by 
cellular stresses, particularly those which deplete ATP levels 
and hence (by means of the adenylate kinase reaction) elevate 
AMP [1]. AMPK phosphorylates multiple targets, particularly 
key enzymes of biosynthetic pathways, and appears to be the 
mammalian homologue of the yeast SNF1 protein kinase, 
which is involved in the response to the stress of glucose starva- 
tion [2-6]. 
AMPK is phosphorylated and activated by an upstream pro- 
tein kinase termed AMPK kinase (AMPKK). We have previ- 
ously demonstrated that 5'-AMP activates the AMPK cascade 
via at least three mechanisms: (i) directly activating AMPKK; 
(ii) binding to AMPK and making it a better substrate for 
AMPKK; (iii) directly activating AMPK [7-9]. Some, if not all, 
of these effects of AMP are antagonized by high (mM) concen- 
trations of ATP [8], so that the system responds to the 
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2, Materials and methods 
2.1. Materials 
Oligonucleotides were synthesised byMiss Audrey Gough on an ABI 
394 DNA synthesizer. The pCW vector was a gift from Dr. A. Roth 
and Prof. R.W. Dalquist. AMPK (435 U/rag) was purified from rat liver 
as far as the gel filtration step [13]. The catalytic subunit of protein 
phosphatase-2A (1100 mU/mg) was purified to homogeneity from bo- 
vine heart using the method previously described for rat liver [14]. 
2.2. Enzyme assays and units 
AMPK was assayed using the 'SAMS' peptide as substrate [15], 
PP2C was assayed using [3ZP]phosphocasein after phosphorylation by
cyclic AMP-dependent protein kinase [16] and PP2A using 
[3~p]phosphorylase a [14], all at 30°C. One unit of AMPK phospho- 
rylates l nmole of peptide per min, whereas 1unit of protein phosphat- 
ase releases 1/zmol of phosphate per min. 
2.3. Bacterial expression and purification of PP2Cot 
The human PP2C~ coding sequence [17] was amplified by poly- 
merase chain reaction using the oligonucleotides 5'-CGCG- 
CATATGGGAGCATTTTTAGACAAGC-3" and 5'-GCGC- 
AAGCTTACCACATATCATCTGTTGATG-3". The first oligo- 
nucleotide creates an NdeI site (underlined) atthe initiating methionine 
codon (italicised), whereas the second creates a HindlII site (under- 
lined) at the terminating codon (italicised) of the open reading frame 
(ORF). Digestion of the PCR product with restriction endonucleases 
NdeI and HindlII allowed the entire ORF to be cloned into the NdeI- 
HindlIl sites of the plasmid pCW [18] to generate he plasmid pCW- 
PP2C~. The sequence of the ORF within plasmid pCW-PP2C~ was 
confirmed by sequencing both DNA strands using Taq dye terminator 
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cycle sequencing on an Applied Biosystems model 373 A automated 
DNA sequencer. 
F~ coli strain DH5~ l(supE44, A(IacZYA-argF)U 169, 
080dlacZDMl5, hsdR17, recA1, endA1, gyrA96, thi-l, relAl, deoR} 
was transformed with plasmid pCW-PP2Ccc by electroporation using 
an 'Easyject plus' electroporator (Equibio). Transformants were plated 
onto Luria Broth LB plates containing ampicillin (100/~g/ml). After 
verifying the sequence of the expression construct, single colonies of 
E. coli containing it were grown to an A6~ ~ of 0.5 at 37°C, and expression 
of PP2Cc~ was induced at 28°C in the presence of 1 mM MnC12, by 
addition of IPTG to a final concentration of 100/~M for 20 h. 
2.4. Purification oj protein phosphatase-2Co~ 
PP2C~ was purified by a modification of the method of McGowan 
and Cohen [19]. Bacteria were harvested by centrifugation (5000 × g; 
10 min; 4°C) then resuspended in 20 ml of buffer A (50 mM Tris-HC1 
pH 7.5, 1 mM DTT, 1 mM EDTA, 0.1 mM EGTA, 100 mM NaC1, 
2 mM MnCI~, 1 mM benzamidine, 0.1 mM PMSF, 0.1 mM TPCK, 0.03% 
(v/v) Brij-35) and sonicated for 4 x 30 s on ice using a Jencons probe 
sonicator (model GE 50). The lysate was centrifuged at 48,000 x g for 
20 min at 4°C, the supernatant decanted, and protein precipitating 
between 30% and 55% saturation with (NH4)zSO4 was resuspended in 
5 ml of buffer B (20 mM triethanolamine pH 7.0, 1 mM EGTA, 2 mM 
MnC12, 0.1% (v/v)fl-mercaptoethanol, 5% (v/v) glycerol, 0.03% (v/v) 
Brij-35). Following dialysis against 1 litre of this buffer for 2 h at 4°C 
with one change of buffer, the sample was loaded onto a Hiload 16/10 
Q-Sepharose column which was developed with a linear gradient (0-400 
mM NaCI, 400 ml). Active fractions (eluting at =230 mM NaCI) were 
pooled and dialysed against 1 litre of buffer B at 4°C for 2 h, then 
applied to a Mono-Q column which was developed with a linear gradi- 
ent (0-400 mM NaC1, 40 ml). Active fractions were pooled, dialysed 
for 2 h at 4°C against buffer B containing 50% (v/v) glycerol, and stored 
at - 20 ° C. 
3. Results 
3.1. Expression R[ PP2C~ in Escherichia coli 
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Fig. 1. Purification of PP2C~ from E. coli. Fractions 1¥om various 
stages of the purification were separated by SDS-PAGE in 12.5% gels 
and stained with Coomassie Blue. Key: 1, crude soluble extract; 2, 
ammonium sulphate; 3, Q-Sepharose; 4, Mono-Q. Mobility of marker 
proteins (molecular masses in kDa) are indicated on the left. 
the E. coli expression vector pCW, allowing expression of the 
full-length protein. Under the conditions used, PP2C~ protein 
constituted =5 10% of soluble protein (Fig. 1). Mn z+ ions were 
included in the culture medium and purification buffers since 
this led to increased specific activity of PP2C (data not shown) 
as reported for human protein phosphatase 1 isoforms ex- 
pressed in E. coli [20]. A simple purification procedure, requir- 
ing only two chromatographic steps, produced essentially pure 
PP2C~ protein migrating on SDS-PAGE with an apparent 
molecular mass of 42 kDa (Fig. 1), as obtained for native 
PP2C~ isolated from mammalian tissues [19]. The specific ac- 
tivity of the purified enzyme against 32p-labelled casein was 100 
mU/mg, which is comparable with that of PP2C purified from 
mammalian tissues (140 mU/mg [19]). 
3.2. AMP inhibits inactivation of AMPK by PP2C and PP2A 
AMPK was purified from rat liver in its phosphorylated, 
active form [13] except hat protein phosphatase inhibitors were 
omitted from the final gel filtration column. Fig. 2A shows that 
homogeneous, bacterially expressed PP2Cc~ caused a rapid in- 
activation of  AMPK.  When added together with PP2C~, AMP 
(200 pM) produced a severe inhibition of this inactivation, 
whereas GMP at the same concentration caused only a slight 
inhibition (< 15%). The AMPK assays were conducted at a 
saturating AMP concentration (200 pM), so that the effect of 
carryover of AMP from the preincubation with PP2C would 
be negligible. This can also be seen from the finding that neither 
AMP nor GMP had significant effects on controls incubated 
without the essential cofactor for PP2C, Mg 2+ ions (Fig. 2, open 
symbols). At a concentration of 200 pM,  both AMP and GMP 
produced a small (= 10%) inhibition of the dephosphorylation 
of [32P]casein by PP2C~ (not shown). 
Fig. 2B shows that AMP. but not GMP, also protected 
AMPK against inactivation by the homogeneous catalytic sub- 
unit of PP2A (PP2Ac), although in this case protection was 
only partial. Expressed per mole of protein phosphatase, 
AMPK was inactivated = 3-fold more rapidly by PP2C~ than 
by PP2A c. 
3.3. Dose--response Jbr effects of AMP and other nucleotides on 
inactivation of AMPK 
The inhibition of inactivation of AMPK by PP2Cc~ at differ- 
ent concentrations of AMP (Fig. 3A) was fitted to a single-site 
model as discussed in the legend to Fig. 3. In the absence of 
ATP, AMP gave maximal inhibition of 84 + 2% (+ S.E.M.), 
with a half-maximal effect (I~.s) at 3.1 + 0.3 ~M. Using PP2A c 
in the absence of ATE the 105 for AMP (3.2 + 0.5/zM) was very 
similar, but the maximal inhibition was lower at 47 + 2% (not 
shown). Using PP2C~ in the presence of 4 mM ATP, the dose- 
response curve for the effect of AMP was shifted to the right 
(Fig. 3A), and the/~5 for AMP was now increased 10-fold to 
34 _+ 7 ~M, with a maximal inhibition of 93 + 6%. 
Formycin A-5'-monophosphate (FMP) is an analogue of 5'- 
AMP which mimics the effect of AMP on allosteric activation 
of AMPK,  albeit with lower potency [7]. Fig. 4 shows that FMP 
also inhibits the inactivation of AMPK by PP2C~. FMP gave 
99 _+ 3% inhibition with a half-maximal effect at 30 _+ 4/ IM (cf. 
hall-maximal effect of AMP: 3.1 + 0.3/~M). Using the same 
preparation of AMPK the A05 values for the allosteric activa- 
tion of AMPK by AMP and FMP were 3.2 + 0.4 and 20 _+ 2 
/zM, respectively (not shown). 
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Fig. 2. Time course of inactivation of A MP-activated protein kinase by 
(A) PP2C~ and (B) PP2A c. AMPK (60 U/ml) was incubated in 50 mM 
Na-HEPES, pH 7.0. 1 mM DTT, 0.02% Brij-35 at 30°C with PP2C~ 
(0.1 mU/ml) or PP2A c (3.2 mU/ml). PP2C~ incubations were per- 
formed in the presence of 20 mM MgCI2 (filled symbols) with controls 
(open symbols) in the absence of MgC12. PP2Ac incubations were per- 
formed in the absence of okadaic acid (filled symbols) or in the presence 
of 100 nM okadaic acid (open symbols), all in the absence of MgCI~. 
Further additions were: none (circles), 5'-AMP (200/zM; squares) or 
5'-GMP (200 pM; triangles). At various times 5/11 aliquots were with- 
drawn for AMPK assay in a total volume of 25 ,ul. 
4. Discussion 
Expression of human PP2Cc~ in E. coli provides an abundant 
source of active enzyme, which can be purified to homogeneity 
more rapidly and in higher yield than from rabbit liver or 
skeletal muscle [19]. The expression vector encodes the entire 
open reading frame, and the protein purified is very similar to 
rabbit PP2C~ both in mobility on SDS-PAGE and in specific 
activity against [32p]casein [19]. Unlike PP2A, where the cata- 
lytic subunit exists in vivo as complexes with other subunits 
which modify its properties [21], native PP2C appears to be a 
monomer [19]. The expressed PP2Cc~ should therefore be a 
useful tool for further studies of PP2C and its substrates. 
In the present paper we analyse dephosphorylation of 
AMPK indirectly by monitoring changes in kinase activity. 
Inactivation was completely blocked in controls (Fig. 2) carried 
out in the absence of Mg 2+ (PP2C:~) or in the presence of 
okadaic acid (PP2Ac), demonstrating that it was a function of 
the protein phosphatase activities in the preparations. Inactiva- 
tion was also reversed by incubation with Mg-ATP and 
AMPKK (not shown, but see e.g. [8]). It is therefore clear that 
the inactivation was due to dephosphorylation. We considered 
monitoring dephosphorylation more directly via a 32P-release 
assay, after labelling of dephosphorylated AMPK using [y- 
~2P]ATP and AMPKK.  However such analyses would be com- 
plicated by the fact that under these conditions the catalytic (00 
subunit of AMPK is autophosphorylated at several sites which 
do not regulate kinase activity, in addition to the single site at 
which it is phosphorylated and activated by AMPKK (D.G.H. 
and S.A. Hawley, unpublished data). Dephosphorylation at 
these other sites may not be regulated by AME The activity 
assay is therefore a more reliable quantitative measure of the 
state of phosphorylation at the AMPKK site. 
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Fig. 3. Dose responses for effects of nucleotides on dephosphorylation 
of AMPK by PP2C:~. (A) Effects of AM P in the presence (filled circles) 
and absence (open circles) of 4 mM ATE (B) Effects of FMP (filled 
circles) with results for AMP (open circles) reproduced from (A) for 
comparison. Results are expressed as the% activity of control incuba- 
tions without nucleotide (100% = 50 U/ml). AMPK was incubated with 
PP2C:~ as described for Fig. 2 but for a fixed time of 7 min and 
at different concentrations of nucleoside monophosphate (NMP). 
Data were fitted to the equation: Activity = 100- (Maxx 
[NMP])/(105 + [NMP]), where Max = maximal inhibition, [NMP] = 
concentration of NMP, and I0 ~ is the concentration of NMP 
giving half-maximal inhibition. Data were fitted using Kaleidagraph 
(Abelbeck software) on a Macintosh SE/30, and the curves are theoret- 
ical curves obtained using values for Max and 105 quoted in the text. 




Fig. 4. Model showing the four mechanisms bywhich AMP promotes 
activation of the AMPK cascade. AMP causes: (i) direct activation of 
AMPKK; (ii) direct activation of AMPK; (iii) promotion of phospho- 
rylation of AMPK by AMPKK; (iv) inhibition of dephosphorylation 
of AMPK. 
tion of AMPK by both PP2C~ and PP2Ac is inhibited by 
5'-AMP. Many phosphorylated compounds have previously 
been shown to cause non-specific inhibition of protein 
phosphatases. This probably explains the small (< 15%) inhibi- 
tion of PP2Cc~ dephosphorylation of AMPK by 200/aM GMP, 
and the = 10% inhibition of [3Zp]casein dephosphorylation by 
both AMP and GMP at the same concentration. However, the 
much larger and more potent effect of AMP on dephosphoryla- 
tion of AMPK is due to binding of the nucleotide to the sub- 
strate (AMPK) rather than to the protein phosphatase. In addi- 
tion, the effect appears to be due to binding of AMP to the same 
site at which it causes allosteric activation of AMPK. The 
evidence for these views may be summarised as follows. 
(1) The 105 for the effect of AMP on dephosphorylation by 
PP2C~ (3.1 + 0.3/aM) was identical to the A05 for the direct 
effect of AMP on kinase activity (3.2 + 0.4/aM). 
(2) In the presence of 4 mM ATE the I05 for AMP was in- 
creased 10-fold to 34 + 7/~M: this concentration f ATP also 
increases the Ao 5 for the direct effect of AMP on kinase activity 
to =30/aM [8]. 
(3) Formycin A-5'-monophosphate, an analogue of AMP 
which activates AMPK with a slightly lower potency 
(A0s = 20 + 2/aM), also inhibits dephosphorylation by PP2C~ 
with an 10s of the same order of magnitude (30 + 4/aM). 
(4) The effect is not specific for a particular protein phosphat- 
ase, because AMP also inhibited ephosphorylation of AMPK 
by PP2Ac with an I0s of 3.2 + 0.5/aM AMP, almost identical 
to that obtained with PP2Cc~. In this case inhibition was only 
partial, with a maximal inhibition of 47 + 2%. 
This study now increases the number of individual mecha- 
nisms by which AMP activates the AMPK cascade to four: i.e. 
(i) direct activation of the upstream protein kinase, AMPKK: 
(ii) direct activation of the downstream protein kinase, AMPK; 
(iii) promotion of phosphorylation f AMPK by AMPKK; 
(iv) inhibition of dephosphorylation of AMPK at the AMPKK site 
(Fig. 4). We believe that these multiple mechanisms would 
ensure that the system responded in an exquisitely sensitive 
manner to any changes in cellular AMP. At least two of these 
mechanisms, i.e. ((ii): [8]) and ((iv): this study) are antagonized 
by millimolar concentrations of ATE The phosphorylation f 
AMPK by AMPKK is also inhibited by high concentrations of 
ATP (D.G.H. and S.A. Hawley, unpublished) and studies are 
currently in progress to determine whether this is mediated by 
binding of AMP to AMPKK (mechanism (i)) or to AMPK 
(mechanism (iii)), or both. Whichever is correct, it is clear that 
the system reponds to changes in the AMP:ATP ratio rather 
than simply to AMP. 
The molecular mechanisms by which AMP has these multi- 
ple effects on AMPK will be an intriguing subject for future 
structural studies. However, it would appear that the kinase 
must exist in at least four different conformational states: 
(i) dephospho-, no AMP; (ii) dephospho-, AMP bound; 
(iii) phospho-, no AMP; (iv) phospho-, AMP bound. Binding of 
AMP to the dephospho f rm causes ashift from state (i) to state 
(ii) and exposes the site for phosphorylation byAMPKK. By 
contrast, binding of AMP to the phospho- form causes a shift 
from state (iii) to state (iv) and shields the phosphorylation site 
against protein phosphatase action. This shielding ismore com- 
plete for PP2Cc~ than it is for PP2Ao which is interesting given 
the evidence that PP2C rather than PP2A is responsible for 
dephosphorylation of AMPK in intact cells [12]. 
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